Market Place
Sourcing Support
All News #Library
Biotech
GC Biopharma Secures CMO Rights for Shingles Vaccine from Curevo
13 Oct 2025 //
PR NEWSWIRE
Curevo Enrolls First Participants in Phase 2 Extension Trial
02 Jun 2025 //
GLOBENEWSWIRE
Curevo Raises $110M for Amezosvatein Shingles Vaccine
17 Mar 2025 //
GLOBENEWSWIRE
Curevo Shares Positive Ph 2 Data For Amezosvatein Shingles Vaccine
12 Jan 2025 //
GLOBENEWSWIRE
Curevo Vaccine to present at 43rd Annual J.P. Morgan Conference
08 Jan 2025 //
GLOBENEWSWIRE
Curevo Presents Positive Shingles Vaccine Outcomes Data
31 Oct 2024 //
GLOBENEWSWIRE
Curevo Vaccine Presents Amezosvatein Shingles Vaccine Data at ID Week
16 Oct 2024 //
GLOBENEWSWIRE
Dr. Chi Li Joins Curevo Vaccine as Chief Regulatory Officer
08 Apr 2024 //
GLOBENEWSWIRE
Curevo’s shingles vaccine equals Shingrix in ph. 2 head-to-head
08 Jan 2024 //
FIERCE BIOTECH
Curevo Announces Positive Topline Results from Phase 2 Trial of Amezosvatein
07 Jan 2024 //
GLOBENEWSWIRE
Curevo Vaccine to present at the 42nd Annual J.P. Morgan Healthcare Conference
21 Dec 2023 //
GLOBENEWSWIRE
Guy De La Rosa, MD, Joins Curevo Vaccine as Chief Medical Officer
11 Apr 2023 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.